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ANNEX  ..................................................  19 L  INTRODUCTION: 
The outbreak of disease due to the Ebola virus in Zaire in  1995,  and  before that,  the 
epidemic of  plague in India in 1994 have focused public attention on the need to take 
action against infectious diseases.  It is  a long-established fact that infectious diseases 
caused by various microbial  agents tend to spread through populations irrespective of 
borders, essentially as a result of the movements of people and,  to a lesser extent,  the 
movement of goods  and  the  consumption of water and  foodstuffs.  Additional  factors 
include  climatic  change  (global  warming),  increased  resistance  to  antibiotics,  the 
immunological status of individuals, and living conditions (socio-economic problems). 
The more that people travel about, and the further they travel,  the greater the risks of 
these diseases spreading in the form of epidemics in unprotected populations and,  as  a 
corollary, the greater the health risks to populations. From Asian flu and cholera, to the 
IDV virus responsible for AIDS, examples abound both in history and in the present day. 
The agents responsible for communicable infectious diseases do not respect geographical 
frontiers.  And despite substantial progress in the field  of public health protection,  the 
exposure of  populations to the risk of  contracting these diseases is increasing all the time. 
In  order  to  take  the  appropriate  measures  necessary  to block  the  progress  of these 
infectious diseases or prevent their appearance, national health authorities clearly need to 
h.ave as precise a picture as possible ofthe epidemiological situation.  Thi~ can only be 
achieved through the systematic collection, analysis and interpretation of data on these 
diseases, followed by their dissemination to those responsible for public health.  Taken 
together these activities amount to epidemiological surveillance, an essentially practical 
process the aim of which is to produce information so that swift action can be taken. In 
the  case  of communicable  diseases  all  the  specialists  agree  that  the  cornerstone  is 
surveillance, with the results being used in order to control and prevent these diseases. 
Epidemiological  surveillance  has  proved  its  worth  over  and  over  again,  the  outlay 
required being amply repaid by the savings made in terms of disease avoidance. 
In this general context, and since infectious diseases can spread easily in the European 
Union  unless  suitable  measures  are taken,  it is obviously  necessary  to  agree  on  the 
measures required for communicable disease surveillance. In this respect the Council and 
the Ministers for Health of the Member States meeting within the Council  adopted on 
13  November 1992  a Resolution, No.  92/C 326/1
1
,  inviting the Commission to report 
briefly on the existing arrangements established between the Member States or by the 
World  Health  Organisation  (WHO)  for  the  surveillance  of communicable  diseases, 
including food-borne  diseases~ to identify needs and  shof!comings~ and to put forward 
proposals for improvements.  And the European Parliament, in its Resolution on  public 
health policy after Maastrichf, invited the Commission to set up a trans-frontier network 
to  devise  working  definitions  of notifiable  diseases,  to  collect,  update,  analyze  .and 
disseminate Member  State data· on  notifiable diseases  and  to work with  national  and 
OJ of 11.12.1992. 





international  agencies on such matters.  Additionally,  in its Conclusions 94/C 15/043  of 
13  December 1993 the Council requested the Commission to put forward proposals for 
the setting up of an epidemiological network in the Community. In its Communication 
COM(93) 559 of 24 November 1993 on the framework for action in the field of public 
health and its Communication COM(94) 413 of 9 November 1994 on AIDS and certain 
other communicable diseases, the Commission proposed specific Community measures 
in this respect, notably the creation and development of surveillance networks. 
Without claiming to be exhaustive, this present Communication reviews the existing inter:. 
institutional  collaborative arrangements for the surveillance of communicable diseases 
in the European Union. After an explanation of  th_e specific nature of  the epidemiological 
surveillance of communicable diseases,  there  then  follows  an  attempt to  analyse  the 
strengths and weaknesses of  the present situation pn the basis of certain objective criteria 
the aim of which is to meet the requirement for a high level of health protection within 
the European Community. Finally, proposals are put forward for short-and medium-term 
surveillance actions for the prevention and control of communicable diseases in- Europe, 
with due regard to the fundamental principles which underpin the construction of  Europe, 
namely subsidiarity and Community added value. 
ll.  THE  SPECIFIC  NATURE  OF  THE  EPIDEMIOLOGICAL 
SURVEILLANCE OF COMMUNICABLE DISEASES 
Before setting out into this vast area it is essential, in order to avoid potential ambiguities 
arid  misunderstandings, to define the context and the concepts used and to outline the 
scope of  the activities concerned. Such clarification is necessary because we need to have 
a clear and simple idea of what can be achieved by the Community in this area,  and 
because both nationally and at international level there is a profusion of  ongoing, but little 
known, initiatives and a confusing interlacing of  different systems. And on top of  all this, 
there is a specific quality to the surveillance of  communicable diseases which needs to 
be apprecia1ed from the European dimension. 
1  DEFINITION  OF SURVEILLANCE 
For the surposes of  the present communication and decision, epidemiological surveillance 
is defined as the ongoing systematic collection, analysis and interpretation of  ~ealth data 
essential to the planning, implementation and evaluation of public health practice, closely 
integrated with the dissemination of these data to those who need to know for their work 
or  for  decision-making.  Surveillance  is  therefore  the  observation  of certain  health 
phenomena affecting  populations  or groups of populations,· through the  collection of 
different types of data,  so that swift action can be taken if necessary to correct these 
phenomena. In principle, such observation is an ongoing process, continuing for as long 
as the phenomena are liable to occur. It is therefore an active and dynamic process which, 
from  the public  health point of view,  can  o~ly concern situations which are liable to 
evolve rapidly if no steps are taken to correct them. 
3  OJ of 18.1.1994. 
3 In the language of  the epidemiologist, the term "surveillance" is in practice used to cover 
three types of case: communicable diseases; pollution-related health risks; and the safety 
of biological products intended for incorporation to humans.  In this latter case the term 
"vigilance" is used, for example haemovigilance in the case of blood or blood products. 
Naturally,  surveillance can also be carried out for non-communicable diseases such as 
cancers, cardiovascular diseases or mental diseases. But because these diseases develop 
slowly, and because of  the nature of  the information which needs to be collected on them, 
and because there is no call for the type of urgent action called for to block a rapidly 
spreading epidemic, the term "epidemiological observation" is used instead in these cases. 
2  OBJECTIVES OF SURVEILLANCE 
In the field of communicable diseases the objectives Qf epidemiological surveillance are, 
firstly, to ascertain the incidence (number of new cases occurring over say a-.month or a 
year) and the characteristics of a particular infectious disease, and to study its pattern of 
spread ·through time,  space and social  categories,  so as to be able to take appropriate 
counter-measures. The second objective is to detect disease clusters or epidemics, or even 
abnormal health incidents, through a system of warning indicators, so that measures can 
be taken to break the specific transmission chain. And the third objective is to describe 
and measure the risk factors for contracting a communicable infectipn, so as to be able 
to select and implement the most appropriate preventive measures and recommendations. 
These three interdependent objectives, taken together, constitute the basis for the activity 
referred to as the control of communicable diseases. It is not some form of checking up 
on  individuals by  State  officials,  as  is  sometimes  erroneously  feared,  but  merely  a 
question of doing everything possible to stop the spread of a disease and  re-establish 
normal conditions, i.e.  a high level of health protection. 
In addition to dealing with de facto situations, surveillance also serves as an instrument 
for evaluating preventive policies, particularly vaccination policy  .. Finally, surveillance can 
form  the basis for hypotheses which can then be verified by means of epidemiological 
surveys. 
3  PRINCIPLES AND  METHODS OF SURVEILLANCE 
Communicable diseases  have certain basic characteristics which were described in an 
earlier Commission communication (COM(94) 413 of 9 November .1994,  paragraphs 6 
to 15), to which the reader is referred.  To some extent these characteristics dictate the 
surveillance methods which need to be employed, since these diseases are not all alike, 
far from it. 
In practice, and according to epidemiology specialists, surveillance can be carried out· on 
the basis of clinical and/or biological criteria (the data being furnished for example by 
general practitioners and test laboratories) or on the basis of surveys (either exhaustive 
or  sample,  depending  on the  type  of disease  under  investigation:  rare  and  serious 
infectious diseases require exhaustive surveys, e.g. compulsory notifications or mortality 
4 registers, whereas common and less serious infectious diseases require sample surveys, 
based  on  networks  of sentinel  doctors  and  sentinel  laboratories).  The  validity  of the 
surveillance depends on the frequency of data collection, which may  be continuous or 
periodic (but repeated at sufficiently close intervals). Data may be collected passively (i.e. 
by awaiting the arrival of  the information) or actively (i.e. through regular or permanent 
contact with the information source). 
Surveillance also depends on the geographical level (i.e. local, national or intemational), 
and the data transmission medium must be the most appropriate for the requirements, 
particularly as regards speed (e.g. written questionnaire. telephone. fax or electroni~ liMa 
transmission).  Additionally,  a truly rigorous surveillance operation should make use of 
at least two independent and complementary surveillance systems for the same disease: 
the exhaustiveness and representativeness of the data collected can then be verified by 
comparing the data from the different systems. 
Obviously, to enable an overall picture of  the situation to be obtained all the surveillanc~ 
data must be collated at a certain central level, which means the national level in most 
countries (leaving aside those with a federal  structure). The same applies at European 
level: the data need to be centralised so that they can be processed and sent out to the 
health players. 
4  THE DIFFERENT SURVEILLANCE SYSTEMS 
A  number  of different  surveillance  systems  on  communicable  diseases  are  m  use 
nationally or regionally. 
a)  The classic system is the compulsoty notification system: general practitioners are 
obliged to notify the health authorities whenever they diagnose a particular disease, at the 
same time furnishing a certain number of  additional details. The centralisation of  the data 
allows a dose watch to be kept on the general situation.  This system: works· reasonably 
well in some countries, less so in others (under-reporting) and in most cases is based on 
clinical  diagnosis  with  no  specific  case  definition.  Since  there  is  no  weeding  out of 
duplicate notifications or of unconfirmed cases it cannot be relied on to give an accurate 
picture of the situation. The system is most effective- when the incidence of a disease is 
not too high:  like any passive surveillance system it is not able to record all cases of a 
disease. 
b)  For the above reasons, the compulsory notification system is very often replaced 
or augmented by networks of  sentinel general practitioners. These are volunteers, forming 
a representative sample of 1 to 4% of the total number of general practitioners in their 
country  in  terms  of age,  sex,  type  of practice  and  place  of practice.  These  doctors 
increasingly tend to be linked up electronically and their .surveillance results are updated 
weekly so that a close watch can be kept on the pattern of occurrence of the diseases 
under surveillance.  This system is used in particular for common diseases with a high 
incidence,  since trends can  quickly be spotted and  information can be exchanged  and 
warnings issued rapidly,  almost in real time. 
5 c)  Networks of  medical biology sentinel laboratories, recruited on the same principles 
as those used for the sentinel doctors, furnish information on microorganisms (viruses, 
bacteria, germs, etc.) which they have identified in their day-to-day work, usually in tests 
to confirm  clinical  diagnoses.  Several  such  networks  have  been  set up for  particular 
diseases, and they play an important role in sounding the epidemiological alarm. Not all 
Member States have set up such networks, which require considerable organisation and 
constant motivation, i.e.  a significant outlay in terms of resources. 
d)  Specialist reference centres for communicable diseases pr:ovide additional support 
throu_g!l  their expertise (identification of strains, epidemiological analysis); through the 
~-warnings  they are able to provide when pomly tc1entinect clusters~  eases of  rare, ----
serious diseases occur; and through the technical advice they are able to give the health 
authorities. 
e)  The range of surveillance systems is completed by periodic or one-,pff surveys, 
e.g.  for  studying  prevalence (nosocomial  infections),  evaluating  preventive  measures 
(vaccination cover) or determining the incidence of certain unmonitored diseases. Other 
information  sources  (death  certificates,  sales  of medicaments  and  vaccines,  health 
certificates,  hospital  morbidity  records,  etc.)  are  also  used  in  order  to  validate  the 
surveillance systems indirectly. 
5  QUALITY OF SURVEILLANCE SYSTEMS 
The usefulness of a country's surveillance system to public health officials will depend 
on  the  quality  of the· system,  i.e.  its  capacity  to provide  an  accurate  picture of the 
epidemiological situation, as assessed by reference to a number of criteria. This is even 
more true at international level: a surveillance  syste~ at Community level would serve 
little purpose if data were not comparable.  , 
a)  The sensitivity of a surveillance system, i.e. the proportion of cases picked up by 
the  system  compared  with  the  total  number  of cases  actually  occurring  in  a  given 
population,  is  a  key  assessment  criterion.  By  this  yardstick,  the  sensitivity  of the 
compulsory notification systems ranges from 5% (of cases reported by comparison to the 
true total) to almost 100%. In these circumstances, where the notification rate achieved 
is below a threshold of somewhere between 50 and 80% there must be serious doubts 
about  the  usefulness  of the  system,  and  the  system  will  need  to  be  improved  or 
augmented with other information sources. 
b)  The representativeness of a surveillance system is, by definition, a key  criterion 
in sample-based systems such as the sentinel networks. This is particularly true when the 
sensitivity of the accompanying compulsory notification system is low, since this could 
drastically alter the true picture and lead to a false assessment of the situation. 
c)  The notification period, if too long, can cause problems, especially in situations 
where effective action is needed in order to control an epidemic as quickly as possible. 
Thus, while annual or quarterly notification of new cases may be appropriate for diseases 
which do not require immediate control measures, it is frankly inappropriate for diseases 
6 where rapid intervention is required.  This factor is particularly important when we are 
dealing with a vast geographical area such as the European Community . 
• 
d)  The  reliability  of the  results  collected  depends  directly  on  whether  cases  are 
defined, or whether a person can be examined by several different doctors in succession, 
or is seen several times by the doctor because of relapses. 
e)  The confidentiality  of the  data  collected raises  ethical  and  legal  problems  in 
particular when the notification questionnaire enables the individual to be identified and 
includes  questions on  the  sexual  behaviour of the  individual  or questions which  can 
identify the individual as  being illY positive.  There are strong reasons,  therefore,  for 
making the questionnaires anonymous. 
f)  Other factors also play a part in the assessment of surveillance systems: two key 
factors which can compromise the usefulness and smooth functioning of a surveillance 
system  are,  firstly,  the  absence  of  additional  data  frequently  essential  for  the 
epidemiological  surveillance of a given  disease,  and,  secondly,  the  lack of sufficient 
manpower to enable surveillance activities to be maintained at an appropriate level and 
the data to be analysed exhaustively. 
ill.  INTERNATIONAL COLLABORATION PROJECTS IN THE FIELD OF 
DISEASE SURVEILLANCE 
Historically, and quite naturally, many of  the exi~ing international communicable disease 
surveillance projects involying different countries or their specialist institutions have been 
set up on the initiative of, and under the aegis of, the World Health Organisation.  The 
WHO's span in Europe extends far beyond the discontinuous territory of the countries 
which make up  the European  Community.  Leaving aside the diseases  covered by the 
International Health Regulations (IHR), these cooperation projects are voluntary, and their 
effectiveness depends on the commitment shown by the partners in collecting relevant 
data and transmitting the data for analysis and dissemination. 
These useful- in some cases vital- transnational activities p.ecessarily have a cost, both 
in terms of investment and operation. The European Community, and more specifically 
the  European  Commission,  has  provided  substantial  financial  support,  usually  in 
cooperation with WHO. 
In  order to obtain as  complete a picture as  possible of the  networks  of public  health 
players  specialising  in  the  surveillance  of communicable  diseases,  the  Corr.mission 
requested a small group of experts, at the end of 1993, to produce an inventory of such 
networks, using a questionnaire for completion by health experts in the Member States. 
For the purposes of the survey, international collaboration was taken to be any activity 
geared towards improving the fight against one or more communicable diseases, and for 
which personnel had been enlisted, whether for a limited duration or otherwise, in at least 
three European countries.  The list of collaboration projects identified,  together with a 
description of each of them, is described in the Annex. 
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i 1  SYSTEMS SET UP BY WHO 
This is not meant to be an exhaustive analysis of all of WHO's activities in this field.  It 
is simply a brief outline of the systems operated by WHO which concern the European 
Community. 
a)  The International Health Regulations (IHR), adopted by the 22nd World Health 
Assembly in 1969 and subsequently amended for cholera by the 26th Assembly in 1973, 
and  for  smallpox  by  the  34th  Assembly  in  1981,  are  designed  to  help  prevent  the 
international spread of diseases. The Regulations oblige all countries which are party to 
this  international  Convention  (this  includes  all  the Member  States  of the  European 
Community but not the European Community itself) to take measures to stop the spread 
of epidemic outbreaks due to three communicable diseases: plague, cholera and yellow 
fever. Breaking with traditional control measures such as quarantine, which are usually 
inappropriate, these measures consist of the continuous epidemiological suryeillance of 
imported cases, the early detection of  infections and their notification to WHO within 24 
hours, and the rapid and widest possible dissemination of  all relevant information. These 
three diseases are not rife in Europe, being imported diseases which have their sources 
in other parts of the world. WHO is the pivot for the Member States for the notification 
of cases. 
The system remains something of a formality, however, and does not produce extensive 
cooperation be~een  the participating countries when incidents of  these diseases occur on 
their  territories.  No  international  convention  can  be expected  to foresee  all  disease 
eventualities. In some cases diseases and disorders other than those covered by the IHR, 
for  example  certain  African  haemorrhagic  fevers,  can  be  tackled  by  the  national 
authorities  in  the  same  spirit.  But in the  light  of experience  the  SY.Stem's  practical 
feasibility is such that it is difficult to see how Community cooperation could be of  value 
in this area. 
b)  The other international exchange systems under the WHO's aegis are concerned 
more with passive surveillance. Some of them merit closer attention. 
* The Expanded Programme on Immunisation (EPI), established by WHO in 1974, aims 
to control  six  diseases of children  throughout the world (diphtheria,  neonatal  tetanus, 
whooping  cough,  poliomyelitis,  measles  and  tuberculosis)  through  appropriate 
immunisation cover. For the WHO's European zone, which covers 50 countries (including 
Russia and the 15 Community Member States), WHO objective No.5 is slightly different, 
namely to control six diseases (the same six as above, but with mumps and congenital 
rubella replacing tuberculosis and whooping cough) in the general population by the year 
2000.  The·Member States are in addition committed to the following four  objectives: 
eradication of poliomyelitis by the year 2000; elimination of neonatal tetan,IS by  1995; 
95% reduction in measles mortality and 90% reduction  in measles morbidity by 1995; 
routine vaccination against hepatitis B by 1995 if  the prevalence ofHBs antigen carriage 
is more than 8%, and vaccination of exposed groups against hepatitis B by  I 997 if the 
prevalence of HBs antigen carriage is less than 8%. 
8 These objectives are merely recommendations, i.e. they have no binding force, and their 
attainment therefore depends on the goodwill  of the national  public health authorities, 
whose representatives  sit in  a management  group  and  an  advisory  committee.  These 
authorities send in their surveillance results, in principle on  an annual basis:  the results 
are  of course  a  vital  tool  for  verifying  the  implementation  of any  immunisation 
programme.  But the fact  is that the Member States are far from  being united in their 
surveillance  methods (case definitions)  and their methods of determining  vaccination 
coverage, thus hampering proper comparison of national situations. 
* Two  other  systems,  the  Collaborating  Centre for  Health  and  Disease  Surveillance 
·(Rome)  and  the  Surveillance  Centre  for  the  Control  of Food-borne  Infections  and 
Intoxications in Europe (Berlin) no longer appear to fulfil  present day requirements. 
2  SYSTEMS SUPPORTED BY THE EUROPEAN COMMUNITY 
At the level of  the European Community, Council Directive 92/117/EEC" of  17 December 
1992  concerning  measures  for  protection  against  specified  zoonoses  and  specified 
zoonotic agents in animals and products of animal origin in order to prevent outbreaks 
of  food-borne infections and intoxications provides for a system for collecting information 
on specified zoonoses and zoonotic agents. Under Article 5, Member States are obliged 
to produce a report by  31  March each year on the trends and sources of the zoonotic 
infections recorded during the previous year, and the Commission is obliged to evaluate 
the information thus obtained and report to the Standing Veterinary Committee before 1 
October each year. Leaving aside these developments, which are not directly within the 
remit of  this Communication, initiatives in the field of  communicable disease surveillance 
have been developed over the last decade in four areas.  The first were in the Research 
sector, followed by technology development initiatives in the Telecommunications and 
Internal Market sectors, where substantial resources have been allocated. Since the entry 
into force of  the Treaty establishing the European Community, the Commission has been 
endeavouring to support innovatory initiatives or to accompany the Community's overall 
activities in the context of the Framework for action in the field  of public health.  The 
need  to  coordinate  these  crucial  public  health  activities  so  as  to  ensure  clarity  and 
coherence is now greater than ever. 
a)  The Eurosentinel system is the product of a concerted initiative launched in 1988, 
funded for three years by the Biomed programme (medical and public health research). 
Its mandate was to promote the establishment of  networks of  sentinel general practitioners 
and  to coordinate their activities in certain Member States, with the ultimate target of 
establishing  a  European  sentinel  surveillance  network  using  electronic  data 
communication resources.  At national  level  these sentinel  GPs  form  networks  for the 
rapid dissemination, in standardised form, of information they gather during the course 
of  their work, and they report their observations to a central national structure. In the case 
of Eurosentinel the central  structures are linked up to a central unit within the Institut 
d'Hygiene et d'Epidemiologie in Brussels, the role of which is to receive and  store all 
4  OJ No L 62,  15.03.1993, p.  38. 
9 information  relating  to.  activities  in  the  field  of sentinel  surveillance, to assist  and 
technically advise the networks, to organise scientific meetings and to publish a regular 
newsletter. 
Placed under the aegis of the Project Management Group, Eurosentinel has the task of 
observing the ·international incidence of  four health matters, based exclusively on clinical 
diagnosis: measles, mumps, prescription ofiDV screening tests and influenza syndromes. 
Initially comprising the existing networks of  five countries (Belgium, France, Netherlands, 
United Kingdom and  Switzerland), Eurosentinel has since been joined by new networks 
set up  in four other countries (Ireland, Portugal,  Spain and Italy).  These networks, of 
variable coverage and quality, are far from  uniform in their organisation.  Their results, 
based exclusively on clinical diagnosis (with no biological confirmation), are tinged with 
uncertainty,  the  more  so  as  there  is  no  common  definition  of cases.  Despite  the 
discontinuation of Community  support the system  continues to function  thanks to the 
support of health authorities of these Member States.  -. 
b)  Telematic Networks. between Administrations 
i) CARE - Early warning system 
Public  health  authorities,  whether  at  local,  regional  or  national  level,  have  the 
responsibility to ensure that the necessary information concerning cases of  communicable 
diseases  liable  _to  lead  to  epidemics  or  epidemic  outbreaks  is  available  and  is 
communicated in good time to all decision-making bodies and/or bodies responsible for 
implementing appropriate measures. 
The effectiveness and efficiency of national administrations in <:arrying  out these tasks 
will be greatly enhanced by the setting up of  an EU-wide modem, cost-effective and user-
friendly telematics system, linking health administrations in the Member States, so that 
they can exchange reliable information, results and experience in real time, consult each 
other prior to introducing counter-measures as in the case of epidemics, coordinate their 
responses, particularly where these might have economic and social consequences, and 
improve the formulation of policies and the planning, financing and administration of 
health services.  · 
The Council decision of 6 November 1995 on support for IDA (telematic interchange of 
data between administrations in the Community)
5  foresees two projects in the field  of 
health, namely CARE (two sub-projects : early warning system and pharmacovigilance) 
and REITOX (European network of information on drug addiction). 
The two CARE sub-projects under IDA are spin-offs of earlier efforts on the European 
Nervous System (ENS-CARE) supported by the Commission under the 3rd Framework 
Research and Technological Development Programme over the period 1991  to 1993; its 
current situation permits the gradual passage  "from rhe pilot to the exploitation phase, with 
s  OJ No L 269,  11.11.1995, p.23. 
10 the general  architecture and infrastructure for communicable diseases,  health data and 
indicators and pharmacovigilance. 
Under  current  IDA  plans,  CARE-Early  warning  system  (CARE-EWS)  work  will 
concentrate over the next two years on development of  the pilot system between national 
administrations, while strictly adhering to the general  system architecture foreseen for 
IDA. Apart from the infrastructure and architecture aspects of a system such as CARE-
EWS linking national administrations, the content of information to be exchanged will 
have to be determined. This will have to be specified by the Commission in collaboration 
with the administrations.  To this  end,  the Commission is  presenting a  proposal  for, a 
decision  by the European Parliament and the Council  concerning the setting up of a 
European  Community  system  for  the  epidemiological  surveillance  and  control  of 
communicable diseases, 
The Commission has already presented a communication and a proposal fo..r  a decision 
on a programme concerning health data and indicators.
6 The latter programme, as distinct 
from the effort directed towards communicable disease surveillance, aims at providing the 
necessary information on health status and health determinants and would, as appropriate, 
draw from  information generated by communicable disease  surveillance.  It does  not, 
however, have the objective of securing the rapid sharing of detailed, validated and in 
most cases confidential information, and the coordination of responses,  when cases of 
communicable diseases liable to lead to epidemic outbreaks occur.  · 
-
ii) The G7 Global Healthcare Applications Project 
r 
The G7 Global Healthcare Applications Project contains a sub-project, "Towards a Global 
Public Health Network", a key element of which is the design of an international  data 
exchange  in  the  areas  of  communicable  disease  surveillance  through  new 
telecommunication  technologies.  These  activities  take  into  account  the  experience 
acquired from the "Wonder project" run by the USA's "Centers for Disease.Control", as 
well as the recommendations made to the President of the United States by the National 
Science and  Technology  Council  in the report  "Infectious disease  - a  Global  Health 
Threat". This detailed report presents an overview of the problems and of the obstacles 
to combating infectious diseases and proposes a step-by-step model for the adoption of 
appropriate measures, including a Worldwide Communication Network. 
c)  European Centre for the Epidemiological Monitoring of  AIDS 
This  Centre,  financed  by the European  Community  in  the  context  of the  BIOMED 
research programmes and the Europe against AIDS programme, was set up in 1987 in 
Paris. It is responsible for the surveillance of AIDS and HIV infection in the European 
Community and the other territories covered by WHO Europe, with whom it collaborates. 
The Centre receives non-aggregated data on diskette every  three  months from  all  the 
countries  in the WHO's European zone, which extract the data from their national data 
bases. They include various indicators concerning the disease and its diagnosis, together 
.  6  COM 95 (449) of 16.10.1995. 
11 with comments on the trends over the past three months. The data are depersonalised so 
that it is not possible to identify the individuals concerned, whatever their geographical 
location.  The  Centre  also  produces  tables  of figures  and  collects  data  concerning 
anonymous screening programmes. 
d)  Ongoing surveillance activities 
Currently, because  Member States' surveillance systems differ so widely, the data issued 
by Member States on communicable diseases are not intercomparable. In addition, not 
enough epidemic outbreaks are detected and correctly investigated. In such circumstances 
it is only rarely that appropriate recommendations can be formulated, because there is a 
lack of epidemiologists trained in this type of intervention. Field epidemiology, which 
involves the application of epidemiological methods to surveillance, to data production, 
to public health action and to the monitoring of  infectious diseases, is the approach which 
is needed in order to contain and, if possible, clear up epidemics. In this context, there 
is clearly a need for collaboration as regards training students in  the epidemiology of 
commttnicable diseases. 
The development of a cadre of public health personnel with a common knowledge base, 
common  skills  and  a  common  approach  to  epidemiology  could  greatly  stimulate 
harmonised  activities  in  the  field  of public  health,  and  especially  in  the  field  of 
communicable disease prevention. For this reason the Commission has since 1994 been 
providing financ!al  support, under the. programme on AIDS .and other communicable 
diseases, for a field epidemiology training prograptme coordinated by the IHE in Brussels. 
The project involves sending ten or so epidemiologists from the Community  to locations 
in other Member States for a two-year period in order to acquire experience and skills 
in  the  field  of epidemiological  intervention  (control  of communicable  diseases)  -
something which  is  lacking  in the Community  at present.  Thanks  to this  innovative 
project a  new network of specialists in  the surveillance of communicable diseases  is. 
gradually ~merging, and this network should be up and running properly within the next 
two or three years. 
In a similar context, the AIDS Centre in Paris is currently coordinating a feasibility study 
for the creation of a European bulletin of communicable diseases, which would publish 
surveillance data on a monthly basis. The producers of  the national bulletins have already 
set up a coordination structure, in liaison with the national institutions responsible for 
surveillance in thCl Member States, with a view to setting up such a bulletin permanently 
at European levef This bulletin would regularly publish data from  existing and future 
surveillance networks and from  epidemiological surveys; would compare the different 
national  approaches  to  public  health;  and  would  collect information  of international 
interest from the Member States' national bulletins. 
3  OTHER NETWORKS 
As shown in the Annex, other international networks of a  similar nature have been set 
up by surveillance professionals in the public sector, sometimes in collaboration with the 
private pharmaceutical  industry,  as  is the case for influenza.  Other networh concern 







IV.  REVIEW  OF  THE  EXISTING  SITUATION  AND  PROPOSALS  FOR 
FUTURE COMMUNITY ACTION 
1  ASSESSMENT OF THE EXISTING SITUATION 
Since detailed information on all  the factors necessary for a rigorous assessment is not 
available,  it is  not  easy  to  provide  an  in-depth  analysis  of the  existing  situation 
concerning disease surveillance at Community level,  still less so to deliver a judgment 
on it However, it is useful to review the situation on the basis of  a checklist, whether this 
be of diseases grouped together thematically,  or of modes of transmission,  or of the 
criteria which determine the quality of a surveillance system, as mentioned at .point II.S. 
The criteria for assessing the pertinence of a surveillance operation and.the suitability of 
the existing system or systems can be organised as follows: 
a)  By type of disease:  . diseases preventable by vaccination 
. sexually transmitted diseases, hepatitis B, AIDS/IllV 
. hepatitis (C and unclassified) 
. food-borne diseases 
. zoonoses (for the record) 
. imported diseases 
. respiratory diseases (tuberculosis) 
. nosocomial infections 
b)  By modes of transmission: 
1. water-borne: 
2.  zoonotic: 
3.  food-borne: 
4.  inter-human: 
- cholera, hepatitis A,  legionellosis (water quality) 
- brucellosis,  trichinosis,  campylobacter,  echinococcosis, 
rabies,  Yersinia,  etc. 






- sms (syphilis, chlamydiases, genital herpes) 
- tuberculosis 
- hepatitis B and C 
- influenza and influenza syndromes 
- meningitis:  Haemophilus  injluenzae  B;  meningococci, 
A,B,C; pneumococcus 
-etc. 
l3 - HIV/AIDS 
- hepatitis B and C 
- etc. 
6.  environmental:  - legionellosis 
- aspergillosis (nosocomial infections) 
-etc. 
7.  parti cui ar:  - Creutzfelt-Jakob disease 
-etc. 
c)  By the criteria determining the quality of a surveillance system: 
. sensi ti vi ty 
. representativeness 
. notification frequency 
. reliability 
. confidentiality 




In the light of this general review it could be possible to compare the existing situation 
with  what  could theoretically  be  done  in  the  way  of disease  surveillance.  The 
Commission,  working  in  close  cooperation  with  the  Member  States'  authorities 
responsible for communicable disease surveillance,  intends to put forward  appropriate 
proposals for the adoption of  measures necessary to improve this type of  epidemiological 
surveillance in the Community. It is already clear that tuberculosis and hepatitis C, which 
the Commission mentioned in its Communication (COM(94) 413), should be considered 
under this approach as meriting particular attention. 
As a general rule, it appears that collaborations are becoming more sophisticated, with 
increasingly standardised methodology and better technical support. Projects which were 
developed within single institutions, without an effective partnership between partners, 
have tended to be less  successful.  Of course,  the opposite is true (when the various 
opposing elements are all  brought together).  Historically, projects Qad  not always had 
clear objectives underpinned by an effective setting of criteria and scientific standards. 
Ongoing, independent scientific input is essential for a project to be successful, and has 
not always been present. 
The strength of any collaboration depends on the quality of the data at the point where 
it  originates  and  therefore  relies  on  the  quality  of national  systems,  which  are 
heterogenous.  Procedures such as coordinating and improving existing systems (rather 
than  developing  new  systems)  and  developing  uniform  agreed  case  definitions,  are 
important  to  the  development  of effective  collaborations.  Clearly,  within  any  one 





2  CONCLUSIONS 
Mter examination of the various international  cooperation schemes  for  communicable 
disease surveillance, and after consultation by the Commission of national experts and of 
those responsible for disease  surveillance in  the Member States,  a certain  number of 
conclusions, on which there is agreement, can be drawn. 
a  - There  is  a  growing  need  for  European  collaboration  on  the  prevention  of 
communicable diseases and such collaboration should be accorded the highest priority. 
Reasons for this include: the increasing mobility of populations due to tourism, business 
and  migrations  in  general;  the  increasing  freedom  of movement  for  goodl);  the  re-
emergence  in  Europe  of once  familiar  infectious  diseases  such  as  tuberculosis  and 
poliomyelitis; the emergence of new infections,  such as those due to various strains of 
E.  coli 0157 secreting cytotoxins; the breakdown of communicable disease prevention 
measures in various parts of eastern Europe, etc.  --.. 
b  - In order to  promote  effective  preventive  action  against  communicable  diseases, 
European  Community  collaboration  in  the  fields  of public  health  surveillance  and 
microbiology is essential. At present, there is not even a list of  structures and laboratories 
to enable analyses and identifications to be carried out at Community level. 
c - The fact that various joint surveillance projects are being considered, or {lfe starting 
to see  the  light of day,  shows  that  the  need  for  European  collaboration  is  widely 
recognised. However, since there are clearly gaps, overlaps and wide variations (in terms 
of quality,  quantity,  uniformity over time,  and  reliability)  in the  data yielded  by  the 
present systems, these activities need to be coordinated within the Community. 
d - There are currently wide differences in the Member States' vaccination programmes 
and  schedules.  The  improvement  of surveillance  and  of research  to  facilitate  the 
harmonisation of  vaccines would bring much-needed rationalisation to this area of  public 
health. 
e - In order to improve surveillance at European level there is a 'need to identify more 
precisely those areas in which there is duplication of activity and to establish priorities 
for the implementation of collective projects.  Accordingly, there is a need to promote 
collaboration between experts from the national institutions responsible for communicable 
disease surveillance. Activities in this domain ought to be coordinated with the activities 
already being carried out by the World Health Organisation, particularly WHO/Euro. 
f - The establishment of contact networks, which are necessary for the development of 
these activities, would be facilitated by the organisation of regular meetings between the 
experts responsible for the national surveillance programmes. These meetings should be 
devoted to the public health problems inherent in communicable disease  surveillance, 
microbiology and identification of the problems and priorities at European level. 
g - All the Member States without exception should participate in such a network, with 
full  account being taken of the fact  that the degree of surveillance and  prevention of 
communicable diseases  varies  substantially  from  country to country.  Since  infectious 
15 diseases know no frontiers,  con.sideration  should be given to extending the network to 
include neighbouring  non-Member States  or countries with  special  relations  with  the 
Community (such as the USA), on a basis yet to be defined. 
h - Several of  the existing European surveillance networks for certain specific infections 
could serve as models for other infections, since they employ standard case definitions 
and  methodologies  agreed  on. jointly by  the  participants  and  transmit  their regularly 
updated data to a coordinating centre at regular intervals. The following are examples of 
high interest: 
•  The  system  for  notifying  AIDS  and  mv  cases  to  the  European  AIDS 
Epidemiological Surveillance Centre in Paris, resulting in trend data which constitute a 
useful basis for preventive action. This example. could be followed in order to develop 
similar information systems for hepatitis, tuberculosis and sexually transmitted diseases. 
•  The  EWGLI  information  system  for  laboratory-diagnosed  legionellosis  cases, 
coordinated by the Public Health Laboratory Service's (PHLS) Communicable Disease 
Surveillance Centre in London, which permits the swift detection of epidemics with a 
common  source.  It provides trend  data,  enabling preventive measures  to  be taken as 
quickly as possible.  A similar system,  SALMNET,  is proposed for salmonellosis and 
could also be applied to listeriosis and infections due to strains of  E.  coli OJ 57 secreting 
verotoxin. 
i  - To  achieve  greater  harmonisation  in  areas  such  as  quali'ty  control  and  the  most 
sophisticated techniques (e.g. phage typing and genotype establishment, identification of 
viruses responsible for African haemorrhagic fevers) used for identifying micro-organisms 
with ever greater precision. 
3  FUTuRE AcrioNs 
a)  On  the  basis  of these  conclusions,  there  will  be  two  major  strands  to  the 
Community's future actions concerning communicable disease surveillance and control: 
- Firstly,  the  establishment  of a  system  for  the  surveillance . and  control  of 
communicable  diseases  at  Community  level,  requiring the  exchange,  at .appropriate 
moments, of  accurate and reliable information concerning diseases for which specific case 
definitions,  identifications and  verifications  are required.  lt is  proposed to set up  this 
system on the basis of a European Parliament and Council decision,  and to exploit the 
infrastructure set up by the IDA progr~me. 
·- Secondly, various measures such as the development and coordination ofintra-
Community collaborations;  assistance for  pilot projects to facilitate  the setting up  and 
smooth running of the key elements of surveiJlance systems at national level; exchanges 
of experience,  notably  through  meetings  of experts;  cooperation  with  non-member 
countries and  international  organisations  competent in  this  field;  the training of field 
epidemiologists;  the  production  and  dissemination  of  information  tools,  such  as 
epidemiological  surveillance  bulletins;  support  for  European  micropiologists  for  the 
16 creation of an  inventory of collaborative ventures in Europe and of national  resources 
currently  available  in  the  relevant  fields  of microbiology.  These  measures  will  be 
undertaken in the context of the future programme concerning AIDS  and certain other 
communicable diseases,  for which the Council  adopted  a common position on 2 June 
1995 (OJ 95/C 216/02)7 and which was the subject of a conciliation procedure, pursuant 
to Article 189b of the Treaty,  on  19 December 1995. 
b)  As  regards  the  setting  up  of a  system  for  the  surveillance  and  control  of 
communicable diseases at Community level, the Commission,  in its communication of 
24 November 1993 on the framework for action in the field of  public health, outlined the 
principles and strategies to be followed in implementing Community activities directed 
towards the attainment of  the health protection objectives laid down by Articles 3(o) and 
129 of the Treaty establishing the European Community. The role of the Community is 
to underpin the efforts of the Member States in the public health field,  to assist in the 
formulation  and  implementation of objectives and  strategies,  and  to  contri~ute to the 
continuity of health protection provision across the Community, setting as a target the 
best results already obtained in a given area anywhere in the Community. 
The Commission's proposal for the creation of  such a network advocates that the Member 
States should participate fully in its organisation and implementation. The network's task 
will be to ensure coordination in the collection, processing and exchange of  information 
necessary for the prevention and control of communicable diseases. Focusing on disease 
prevention,  and~ following  the  principles  of subsidiarity  and  proportionality,  this 
Community action is designed to help the authorities responsible for public health to take, 
at State level, measures to block the progression of  these infectious di~eases or to prevent 
their appearance. 
c)  Consequently, this proposal seeks to establish a system of close cooperation and 
effective coordination between Member States in the field of surveillance, both routine 
and  emergency,  with  a view to improving the prevention and  control  in Europe of a 
certain number of serious communicable diseases which necessitate the introduction of 
measures for the protection of populations.  The  proposal  is  modelled on  Community 
instruments already adopted in similar areas for the accomplishment of  similar objectives. 
The data in question will  be collected in  aggregated form  and will  in  no  case enable 
individuals to be identified.  Thus,  they will  not conflict with Community  instruments 
concerning the protection of personal data, such as Council Directive C 95/46/EC of 24 
October 1995 on the protection of individuals with regard to the processing of personal 
data  and  the  free  movement  of such  data
8
•  They  will  however  comply  with  the 
Community  provisions  concerning  systems  of  information  exchange  between 
administrations. 
d)  The setting up of  this network for the surveillance of  communicable diseases takes 
account of, and is based on, the situation already existing in this field at European level. 
It also aims to avoid unnecessary duplication· of  work by ensuring that all Member States 
7 
8 
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17 have the same conception of surveillance, as a result of defining with them the type of 
information required and the arrangements appropriate for each group of communicable 
diseases. Finally, other parties will be associated with the network: these will include  the 
. competent international organisations (notably WHO), the surveillance networks to which 
Member States already belong,  and non-member countries. Cooperation with the USA 
towards the setting up of a global early warning and response system has already begun 
within the framework of the EU-USA action plan, and also within tpe framework of  the 
G7 Global Healthcare Applications Project, in which Canada and Japan are also involved. 
An important aspect of this latter project is the application of new technologies to the 
international exchange of data in the field of communicable disease surveillance. 
e)  The recently ~reated Task Force on Vaccines and Viral Diseases  s~ould also help 
to coordinate efforts to establish a European Communicable Disease Surveillance System 
building on existing pilot activities and legislative initiatives. Its main thrust should be 
to ensure adequate information flows between the vaccine research commun.ity and the 
surveillance networks and to focus on endemic identifiable infections as well as voluntary 
data constituencies on specific outbreaks  .. Furthertnore, the Task Force would catalyze the 
integration of common European  expertise into the surveillance  system  at  a  level  of 
specific laboratory facilities. 
f)  The implementation of the decision will yield added value in a number of  ways: 
It will ensure the setting up of a system of continuous, well-structured, reliable 
and effective communication at Community level between national communicable disease 
surveillance authorities, something which is lacking at present; 
It will facilitate the rapid, reliable and commonly agreed identification of cases 
of communicable diseases  occurring inside the Community,  or occurring outside and 
therefore being imported or likely to be imported; 
It will  give the competent authorities the opportunity and the means to consult 
together on the preventive measures to be taken, and it will help them in the <;oordinated 
introduction of such ·measures and the evaluation of their effectiveness; 
It will give the authorities the support they need for analysing and  interpreting 





I - EXISTING COLLABORATIONS 
A - Surveillance 
1 - WHO Collaborating Centre for Health and Disease Surveillance 
Diseases surveyed 
Notifiable diseases or diseases otherwise subject to systematic/obligatory reporting at a 
national level. 
Data sources 
Periodical  bulletins  of communicable  disease  surveillance  prepared.  by  part1c1pating 
countries,  according  to  the  variable  criteria which  may  apply,  and  supplemented  by 
retrospective cumulative data from  WHO Regional  Office and the statistical office of 
WHO Headquarters. 
International reporting 
Twenty five countries submitted data by post to the centre at the Instituto Superiore di 
Sanita  in  Rome.  Data  is  available  for  Albania,  Austria,  Belgium,  Bulgaria, 
Czechoslovakia, Denmark, Germany, Finland, France, Greece, Hungary, Iceland, Ireland, 
Israel,  Italy,  Luxembourg,  Malta,  Monaco,  Morocco,  Netherlands,  Norway,  Poland, 
Portugal, Romania, San Marino, Spain, Sweden, Switzerland, Turkey, United Kingdom, 
Russia and Yugoslavia  . 
. 
International feedback 
Eight bulletins summarising  disease  occurrence ·by  YEAR by  COUNTRY have been 
produced since the scheme's inception. 
100% provided by participants.  Start up moneys of $3,000 US were provided by WHO 
Regional Office. 
Dates of i) commencement and ii) completion 
i)  1983  ii) ongoing. 
19 Four enquiries have been received in the last 3 years.  The quality of the data reported 
nationally  does  not  merit  the  effort  of international  collation  in  the  views  of the 
Collaborating Centre. 
20 • 
2 - Expanded Programme on Immunisation 
Diseases surveyed 
Incidence of Diphtheria,  Tetanus,  Pertussis,  Poliomyelitis,  Measles,  Mumps;  Rubella. 
Immunisation coverage. 
Data sources 
Generally based on passive reporting via notification schemes in countriesn.  Assessment 
of  vaccine coverage uses different approaches in different countries (see below, "Research 
in Methodologies of Immunisation Programmes Management in Europe"). 
International reporting 
Tabulated data is sent periodically to WHO European Regional Office in Copenhagen. 
International feedback 
. 
A publication summarising immunisation coverage and incidence of six target diseases 
(Diphtheria, Measles, Pertussis, Poliomyelitis, Tetanus and Tuberculosis) is produced 6 
monthly. 
Submission of tabulated data to WHO by participating countries. 
Dates of i) commencement and ii) completion 
i) Longstanding ii) Ongoing 
International comparisons have given an impetus to beneficial modifications of national 
schedules.  Identification of risk  areas  (eg Diphtheria in  the countries of the former 
USSR). 
21 3- Eurosentinel 
Diseases surveyed 
Range of communicable diseases. 
Data sources 
Clinical diagnoses from various networks of  sentinel General Medical Practitioners (GPs). 
Case definitions used vary between networks but are invariably physician based. 
International reporting 
. Weekly  totals  of disease  occurrence  are  sent  by  fax  to the  Institute  of Hygiene  and 
Epidemiology,  Brussels.  Data  is  available  from  Belgium,  France,  The  N;_etherlands, 
Portugal, Spain,  Switzerland and United Kingdom. 
International feedback 
A Bulletin of the Institute of Hygiene and  Epidemiology is  prepared  periodically,  as 
resources  permit,  on  behalf of the  collaborating  networks.  This  tabulates  disease 
occurrences by country by week and is posted to collaborators. 
Submission of tabulated data to Institute of Hygiene and .Epidemiology by participating 
networks.  The Institute of  Hygiene and Epidemiology estimate their input to co-ordinate 
the scheme to be 1 hour of medical staff time, 1 hour of scientific staff time and 4 hours 
of clerical staff time per week ~th  all  inputs since 1991  provided nationally. 
Dates of i) commencement and ii) completion 
i)  1988  as EC concerted  action programme.  ii)  1991  but the Institute of Hygiene and 
Epidemiology has continued the scheme on an informal and unfunded basis since then 
as a service to the collaborating networks. 
Acts as a clearing house for information about activities in the field of sentinel practice 
schemes ·and a source of scientific support for them.  During the 1989 influenza epidemic 
the data was used to review spread through Europe and to encourage vaccination and to 
brief the media in certain countries. 
Potentially  the  scheme  could  support the ·development of sentinel  networks  in  those 
countries which do  not possess them  and also organise international  studies based  m 
those participating networks which are already established. 
22 4 - WHO Surveillance Programme for Control of  Foodborne Injections and  Intoxications 
in Europe. 
Diseases surveyed 
Foodborne disease,  defined as "a disease of an infectious or toxic nature caused by  or 
thought to be caused by th.e consumption of food or water". 
Data sources 
Reporting from the responsible surveillance institution.  Criteria for including data differ. 
Some  countries  consider a  disease  as  foodborne  only  when  the  causative  agent  was 
identified in the patient as well as the food;  other  countries find  it satisfactory when 
there is epidemiological evidence and yet others include all  d~arrhoeal diseases. 
International reporting 
Reporting procedures vary between countries.  Data is sent to the Institute of  Veterinary 
Medicine - Robert von Ostertag Insti~te (F AO/WHO Collaborating Centre for Research 
and Training in Food Hygiene and Zoonoses,  Berlin.  Data is,  or until  recently was, 
available from Albania, Austria, Belgium, Bulgaria, Cyprus, Czechoslovakia, Denmark, 
Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Luxembourg, 
Malta,  Monaco,_ Netherlands,  Norway,  Poland,  Portugal,  Romania,  Spain,  Sweden, 
Switzerlan~, Turkey, United Kingdom, USSR, Yugoslavia. 
International feedback 
Five reports have been published since the schemes inception.  The most recent covered 
the period 1986-1989 and was published in 1992. Data is presented in a series of  country 
reports with little attempt at inter-country comparisons.  More immediate feedback is 
provided by newsletters which are published approximately 4 times per year. 
Submission of tabulated data to Robert von Ostertag Institute by participating networks. 
Dates of i) commencement and ii) completion 
i) 1980 ii) Ongoing.  The programmed is intended to become of  the 4 components of  the 
Food  Safety  Pilot (ie application),  one of the 4  subsidiary  projects  of the European 
Nervous System (ENS) /CARE Telematics programme, funded by European Commission 
to develop European electronic communications networks. 
Stimulus to national authorities in their efforts to strengthen the prevention and control 
of foodborne diseases. 
23 5  - British Paediatric  Surveillance  Unit  (BPSU)  and Union  of European  Paediatric 
Societies and Associations 
Diseases surveyed 
Rare infectious diseases and infection related conditions in patients under 16 years of age. 
(Up to 12 disorders at any one time).  Rare non infectious conditions are also surveyed. 
Infectious diseases which are, or have been, surveyed are IDV/AIDS, Neonatal Herpes, 
Sub-acute  Sclerosing  Pan  Encephalitis,  Haemolytic  Uraemic  Syndrome,  Congenital 
Toxoplasmosis,  Rheumatic  Fever,  Congenital  Rubella,  MMR.  associated  Meningo-
encephalitis,  Acute  Flaccid  Paralysis,  Haemophilus  influenzae  type  B  (HiB)  vaccine 
failures. 
Data sources 
Defined diagnoses of conditions under surveillance reported monthly by a postal report 
card ("orange card") by  1,160 participating hospital paediatricians. 
International reporting 
This  is made to BPSU at the British Paediatric  Association  Offices  in London.  An 
important feature is the requirement to make a nil return if  no cases of the diseases under 
surveillance hav,e  been seen by  the  paediatrician.  Data is available form  the  United 
Kingdom and. Ireland.  Similar but separate schemes have now commenced in Germany 
and the Netherlands. 
International feedback 
Six annual  reports have been published since the schemes inception.  The most recent 
was published in 1993.  Regular scientific publications are made. 
Submission of report cards to BPSU by participating clinicians. 
Dates of i) commencement and ii) completion 
i) 1986 ii) Ongoing.  The Union of  European Paediatric Societies and associations formed 
a working group in 1991 to develop a network of  European paediatric surveillance units. 
· The group includes 9 countries and has applied for EC funding  as  a concerted action 
programme for 1993. 
The scheme has enhanced ascertainment and the provision of data of good quality for a 
variety of rare conditions.  It has been imitated in other countries and is being considered 
by other specialties. 
24 .  ( 
6 - EURO.NES Scheme for Surveillance of  Nosocomial Infection 
Diseases surveyed 
Nosocomial infections and Pneumonia in Intensive Therapy Units (ITUs) to identify risk 
factors,  evaluate control measures and  as~ess the feasibility of a surveillance system. 
Data sources 
For a one month period participating physicians in ITUs form a convenience sample of 
volunteering hospitals .  reported to national  centres the isolation from  their patients of 
microorganisms which were hospital acquired.  Data was available on the age and sex of 
the  patient and the severity  of clinical  illness, .the  procedure undergone,  intercurrent 
illness/therapy, smoking habits and the existence of infection at admission. 
International reporting 
Data was posted to the University of Lyon, France.  Data was obtained from' Belgium, 
Denmark, France, Germany, Greece, Ireland, Italy, Netherlands, Portugal, Spain, Sweden, 
Switzerland, United Kingdom. 
International feedback 
Analysis of  risk factors has been received back from coordinators.  Scientific publication· 
is awaited. 
Study  costs  within  countries  met by  participants.  EC  provided  software,  organised 
meetings and funded collaborative aspects. 
Dates of i) commencement and ii) completion 
i)  1990 ii)  1992: data analysis continuing.  Fieldwork was of 1 month's duration. 
Potential for setting standards for in-patient care  . 
25 7 - WHO Influenza Surveillance 
Diseases surveyed 
Laboratory isolation of influenza virus or serological evidence of influenza infection. 
Data sources 
Specimens submitted by clinicians to diagnostic laboratories within countries. 
International reporting 
Data is sent by post or fax  to the WHO Influenza Collaborating Centres on Influenza 
Reference  and  Research  in  London  and  Atlanta,  USA.  Data  is  obtained  from  46 
laboratories in 25 developed countries and 64laboratories in 52 other countries, covering 
nearly all parts of the world. 
International feedback 
A weekly influenza report is received by fax from Atlanta giving disease occurrence by 
time and  place.  Data also features  in the notices  of influenza activity  in the WHO 
Weekly Epidemiological Record. 
Submission of data by responsible institutes in participating countries. 
Dates of i) commencement and ii) completion 
i) 1990 ir) Ongoing. 
The scheme is critical for knowing the correct strains to incorporate in vaccines.  When 
allied  to  other systems it could allows the epidemiological  characteristics of different  · 
strains to be evaluated. 
Potentially a model for international collaboration  in communicable disease surveillance 
as  well  as  permitting  the  computation  of  the  velocity  of  spread  of  influenza 
internationally. 
26 8 - Influenza (EUROGROG) 
Diseases surveyed 
Laboratory  isolation of influenza virus or serological  evidence of influenza infection 
combined with cl.inical  diagnoses via sentinel schemes and other non-specific indicators 
of  activity  (eg.  hospital  activity,  sickness  absence,  consumption  of  specific 
pharmaceuticals. 
Data sources 
Specimens submitted by clinicians to diagnostic laboratories and various other indicator 
activities within countries. 
International reporting 
Data is sent by post or fax to the Institut Pasteur in Paris. 
International feedback 
A weekly influenza bulletin is sent by post from Paris giving activity (disease occurrence 
by week by country or French Department) in 23  countries. 
Submission of data by responsible institutes in participating countries. 
Dates of i) commencement and ii) completion 
i) 1984 ii) Ongoing. 
The scheme allows the epidemiological characteristics of  different strains to be evaluated. 
Potentially a model for international collaboration in communicable disease surveillance 
as  well  as  permitting  the  computation  of  the  velocity  of  spread  of  influenza 
internationally.  Could lead to more accurate information on, and greater harmonisation 
of, action thresholds. 
27  ' 9- European Working Group on Legionella Infection (EWGLJ) 
Diseases surveyed 
Laboratory evidence of Legionellosis defined according to strict diagnostic criteria in 
patients with a clinical or radiographic diagnosis of pneumonia. 
Data sources 
Case  reporting  via clinicians  and  diagnostic  laboratories  to  responsible  national  co-
ordinating centres within countries. 
International reporting 
Data is  sent by  post,  fax  or computer network to the  PHLS  Communicat>le  Disease 
Surveillance Centre (CDSC), London, the centre having been moved from the National 
Bacteriological Laboratory, Stockholm with a view to incorporating the scheme into the 
Early Warning Pilot, one of the 4 subsidiary projects of the European Nervous System 
. (ENS) /CARE Telematics programme, funded by DGXIU to develop European electronic 
communications  networks  (Appendix VII).  Data is  obtained from  Austria,  Belgium, 
Czechoslovakia, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, 
Norway,  Portugal,  Spain,  Sweden,  Switzerland,  Turkey,  United  Kingdom,  USSR, 
Yugoslavia. 
International feedback 
A computer disk is sent by  post from London, monthly, giving disaggregated data on 
diagnostic  status,  time  (onset  and  report date),  resort visited,  period  of visit,  person 
(characterised by age, sex and country of  residence) and institute of  report.  Cluster alerts 
are also issued. 
Submission of data by responsible instit:utes in participating countries. 
Dates of i) commencement and ii) completion 
i)  1987 ii) Ongoing. 
Unique data source for some participating countries where Legionellosis is not subject 
to  any  reporting/notification  requirements:  Permits  control  activity  where  clusters 
identified.  Strengthens the efforts of national institutions in controlling disease.  Model 
for international collaborative effort. 
28 10 - European Monitoring Group on Meningococci (FMGM) 
Diseases surveyed 
Meningococcal meningitis and septicaemia. 
Data sources 
Case reporting via national centres with responsibility for meningococcal surveillance. 
International reporting 
Data is sent to King's College School of  Medicine and Dentistry, University of London. 
Data is ootained from  Albania,  Austria, Belgium, Bulgaria, Croatia, Czech Republic, 
Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ir:eland,  Italy, 
Latvia, Malta, Netherlands, Norway, Poland, Portugal, Romania, Russia, Slovak Republic, 
Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom, Yugoslavia. 
International feedback 
Periodic reports are provided giving incidence by country by year.  Data on age, outcome 
and prophylactic and curative therapy is also .provided.  Data on serogroups and subtypes 
from reference laboratories and sulphonamide resistance is also given. 
Submission of  data by responsible institutes in participating countries.  The co-ordinating 
centre is funded by the UK National Meningitis Trust (a charity). 
Dates of ij commencement and ii) completion 
i) 1991? ii) Ongoing.  Application to the EC is intended. 
Standardisation of surveillance and laboratory techniques and reagents.  Development of 
an audit process for meningococcal disease management in Europe. 
29 11 - WHO Collaborating Centre for Rabies Surveillance and Research 
Diseases surveyed 
Human and animal rabies. 
Data sources 
Case  reporting  via  clinicians,  veterinary  surgeons  and  diagnostic  laboratories  to 
responsible national co-ordinating centres within countries. 
International reporting 
Data is sent to the WHO Collaborating Centre for Rabies Surveillance and Research at 
the Federal Research Centre for Virus Disease of  Animals, Tubingen, Gennaoy.  Data is 
obtained from Austria, Belgium, Bulgaria, Croatia, Czechoslovakia, Denmark, Estonia, 
Finland, France,  Gennany, Greece,  Hungary,  Iceland,  Ireland, Italy, Latvia, Lithuania, 
Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Russia, Slovenia, Spain, · · 
Sweden,  Switzerland, Turkey, United Kingdom, Yugoslavia. 
International feedback 
A quarterly report is produced tabulating cases by species, by  district, by quarter. 
Submission of data by responsible institutes in participating countries. 
Dates of i) commencement and ii) completion 
i) ? ii) Ongoing. 
Identifies changes in epizootic cycle.  Infonns animal .  immunisation  programmes and 
decisions on offering immune prophylaxis to humans. 
30 (5) 
12 - European Centre for the Epidemiological Monitoring of  AIDS 
Diseases surveyed 
AIDS, and lllV infection. 
Data sources 
Every  thr~ months the national representatives in charge of AIDS surveillance 
systems provide individual anonymous data on diagnosed AID'S  cases.  Data from HIV 




All the countries in the WHQ European Region, including all the European Union 
Member States, participate in the surveillance system. A uniform AIDS case definition 
and standardised methods of  data transmission are used. The Centre collects, analyses and 
disseminates results at European level. 
International feedback 
The data..collected are recorded in quarterly reports which include updated results 
of  AIDS surveillaace and various articles from  seroepidemiologi~ surveys or European 
multicentre studies. There are separate quarterly reports for the WHO European region 
and for the European Union countries.  Twice a year, the EU report includes detailed 
information for each country. Scientific publications are produced by the Centre and also 
}?y other users of  the data sets which are available to surveillance and research teams of 
participa~ng countries.  · 
Data are  sent to the Centre on diskettes  or by E-mail.  Representatives  of the 
participating countries receive copies of the compiled data sets  (quarterly) and sets of 
slides presenting the data (twice a year). The quarterly reports are distributed to a network 
of 900 correspondents. Standardised tables are also available on Internet. 
Dates of i) commencement and ii) completion 
i) 1984 ii) ongoing 
The Centre regularly provides standardised information: allowing the evaluation 
of the IITV/AIDS epidemic situations and trends at European level. It reinforces efforts 
of national and international institutions to control the epidemic and is a working model 
of international collaboration. 
31 B- Training 
1 - lnstitut pour /e Developpement de I'Epidemio/ogie Appliquee (IDEA) 
Participants 
Public health professionals. 
Duration and Locations 
3 weeks at Veyrier du Lac, France. 
Subject matter 
Field  epidemiology  inCluding  a  surveillance  project (usually  a  knowledg~. attitudes,. 
practice survey). 
Instruction is in French. 
Assessment (including formal qualifications awarded) 
Those who complete the course receive a certificate of completion. 
-Benefit to participants 
Enhancement of abilities in field investigation. 
Additional. practical skills to organisation sending student. 
Dates of i) commencement and ii) completion 
i)  1984 ii) Ongoing. 
\ 
32 2 - Seminars on Infectious Disease,  Communicable Disease for Environmental Health, 
Surveillance oj  !Pjection. 
Participants 
Public Health Professionals: c40/seminar. 
Duration and Locations 
5 days: Glasgow (UK). 
Subje<(t matter 
Epidemiology and control of infection suitable for an international audience. 
A~sessment (including formal qualifications awarded) 
None. 
Benefit to participants 
Exchanges of ideas and establishment of  international working relationships. 
Establishment of avenues for information exchange. 
Dates of i) commencement and ii) completion 
i) Longstanding  ii) Ongoing 
33 C - Information 




Articles published in national bulletins of the European Union Member States, 
original  articles regarding investigation or of recent outbreaks reports,  review articles 
based on European data. 
International reporting 
The production of  the bulletin is coordinated by a French-English permanent team. 
The scientific committee is composed of members of the National Public Health Centre 
and the European Centre for the Epidemiological Monitoring of Aids in France, and of 
the Plll..S  - Communicable Disease Surveillance Centre in England.  The -15  Member 
States of the European Union are represented by editors of  national surveillance bulletins 
or by surveillance representatives in the case of Member States without such bulletins. 
They compose the editorial board. 
International feedback 
A  French-English  pilot  issue  was  published  and  distributed  to  professionals 
involved in public health in  1995 (12 000 recipients). An electronic version was set up 
on Internet. Monthly routine production should follow the feasibility study conducted in 
1995, which was funded by DGV of the Commission of the European Communities.  .  . 
Two meetings of the editorial board and six meetings of  the scientific committee 
each  year,  to  select,  appraise and finalise  articles.  Regular contacts by  fax  or E-mail 
ensure close collaboration within the network. The publishing arid mailing of the bulletin 
are carried out by the European Centre for the Epidemiological Monitoring of Aids. 
Dates of i) commencement and ii) completion 
i)  1995  ii)  1998 (for the project submitted to the Commission) 
The  feasibility  study  revealed  genuine  interest  from  readers  (evaluation 
questionnaire) and the European collaborators. 
34 Eurosurveillance aims at increasing the circulation of information in the field of 
communicable  diseases  epidemiology  between  national  surveillance  systems  and 
professionals  involved  in  Public  Health  within  the  European  Union.  Moreover,  the 
establishment  of  close,  regular  contacts  between  experts  in  charge  of  national 
communication should develop the quality and speed of information exchanges beyond 
the bulletin itself and should contribute to better control of communicable diseases in the 
European Union. 
35 D -Other 
Research in Methodologies of  Immunisation Programmes Management in Europe 
Diseases 
Diphtheria, Tetanus, Pertussis, Poliomyelitis, Measles, Mumps, Rubella. 
Activity 
National Immunisation Programme Managers have met together to expedite developments 
in three areas: 
1  Methods used to assess vaccine coverage. 
2  Assessment of surveillance methods used to detect adverse reactions. 
3  Investigation of  outbreaks of  vaccine preventable disease (predominantly to concentrate 
on measles). 
International co-ordination 
International Children's Centre, Paris. 
Inputs 
Funded as EC Concerted Action. 
Dates of i) commencement and ii) completion 
i) 1991  ii) Ongoing 
Pooling of structural and  process data from  participating countries.  Allows sharing of 
experience and notice to be given of potentially helpful technologies (ie salivary testing 
for anti-measles antibodies). 
36 II - PLANNED COLLABORATIONS 
A  - Surveillance 
1-SAIMNET 
Diseases to be surveyed " 
Laboratory confirmed human Salmonella  infection. 
Data sources 
Reporting from the responsible national collaborating centre to the European coordinator. 
Discussions and exchange of isolates is being co-ordinated by the PHLS Central Public 
Health Laboratory, London, to harmonise phage typing on a European basis. 
International reporting 
Reporting would be by regular submission of a floppy disk to the European coordinator 
by  each  collaborating centre.  An exploratory workshop in London was  attended by 
representatives  from  Austria,  Belgium,  Denmark,  France,  Germany,  Ireland,  Italy, 
Netherlands, Portugal, Spain, Sweden, Switzerland, United Kingdom. 
International feedback 
An aggregate  database  would  be  created  and  returned  to  each  country.  The  PHLS 
"Exception Reporting Scheme" will be used to analyse the data to identify anomalously 
high levels of isolation and facilitate outbreak recognition. 
Date of i) commencement 
i)  1993.  The  programme  has  been  fundend  as  an  EC  Concerted  Action  under  the 
BIO:MED 1 Scheme (Science, Research and Development).  The programme is intended 
to become one of the communicable disease components of the Early Warning Pilot (ie 
application),  one of the 4  subsidiary proJects of the European Nervous System (ENS) 
/CARE  Telematics  programme,  funded  by  the  Commission  to  develop  European 
electronic communications networks. 
Identification  of European wide Salmonella problems.  Enhancement of the  ability  to 
detect multi-state outbreaks.  Harmonisation of reference techniques. 
37 2 - CARE.ENS Influenza Surveillance 
Diseases to be surveyed 
Laboratory  isolation. of influenza virus or serological  evidence of influenza infection 
combined with clinical diagnoses via sentinel schemes. 
Data sources 
Reporting from the responsible national collaborating centre to the European coordinator. 
Intemational reportina 
Reporting would be by computer network to the European coordinater at Universite Citi 
2, Paris, by each collaborating centre.  .._ 
International feedback 
It is intended .  that a disaggregated database will  be created for online interrogation by 
participants in the network. 
Date of i) commencement 
i)  1990.  The  programme  is  intended  to  become  one  of the  communicable  disease 
components of  the Early Waming Pilot, one of  the 4 subsidiary projects of  the European 
Nervous System (ENS) /CARE Telematics programme, funded by  the· Commission to 
develop European electronic communications networks. 
May expedite data feedback. 
38 3 - WHO  Global Surveillance Programme for Recognition and Response to Emerging 
Diseases. 
Diseases to be surveyed 
New, emerging or re-emerging diseases and drug resistant micro-organisms. 
Data sources 
Enhanced laboratory reporting at country level to the existing WHO collaborating centres, 
which will be strengthened. 
International reporting 
This will  be to WHO Headquarters at Geneva (Division of Communicable -Diseases in 
close co-ordination with Divisions of  Epidemiological Surveillance, Health Situation and 
Trend Assessment and Emergency and Humanitarian Action). 
Reporting  of  bacterial  resistance  to  antibiotics  would  be  by  computer  network 
(WHO  NET): 
International feedback 
To be. developed .. 
Date of i) commencement 
i)  1994. 
~ 
Enhancement of capabilities  at country  level.  Development of stronger intervention 
capacity at WHO/HQ level to facilitate prompt, co-ordinated action~ Training components 
will be incorporated and research opportunities will develop. 
39 4 - European Study Group on Haemolytic Uraemic Syndrome 
Diseases to be surveyed 
Clinical  diagnoses  of haemolytic  uraemic syndrome and laboratory  isolations of VT+ 
E. coli 
Data sources 
Paediatric dialysis units and diagnostic microbiology laboratories. 
International reporting 
Some reporting is already carried out by post to the University of  Wurzburg in Germany. 
Italy submits some data currently.  Interest has been indicated from Belgium--and United 
~~~.  -
International feedback 
None as yet. 
Date of i) commencement 
i)  Italy and Germany have shared data since 19S8.  The programme had been proposed 
for funding as an EC Concerted Action under the BIOMED I Scheme of the European 
Commission (Science, Research and Development). 
The diseases are of  relatively low incidence, although the sequelae are serious.  European 
surveillance may expedite risk factor identification. 
40 5 - European Network on Congenital Toxoplasmosis 
Diseases to be surveyed 
Congenital Toxoplasmosis for which a clinical and laboratory based case definitions are 
to be developed. 
Data sources 
Participating countries  institutions are to  be  asked  to identify geographically  defined 
populations  of pregnant  women  in  urban,  and,  if possible,  in  rural  areas.  Data  on 
seroprevalence will be compared.  A multi  centre randomised trial of therapy has also 
been proposed and a long term cohort study of  the offspring of  women who sero-convert 
in pregnancy. 
International reporting 
Different  aspects  of the  work  will  be  reported  to  different  co-ordinating  centres. 
Participating  in  the  inaugural  workshop  were  Austria,  Belgium,  Denmark,  Finland, 
France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Sweden,  Switzerland~ 
United Kingdom.  Overall co-ordination is from the Statens Seruminstitut, Copenhagen  . 
. International feedback 
None as yet. 
Date of i) commencement 
i)  1993  The  programme  has  been  funded  as  an  EC Concerted  Action  under the 
BIOMEDI Scheme of the Commission (Science, Research and Development). 
Analysis of  data from a variety of  localities will give indications as to routes of  infection. 
Standardisation and quality assurance at a European level becomes possible of  diagnosis 
and  treatment.  Resolving  uncertainties  about  the  outcomes  of treatment  may  be 
expedited. 
41 6 - Nordic countries case-control study of  listeriosis 
Diseases to be surveyed 
Listeriosis. 
Data sources 
Physicians in participating countries will make a notification of listeriosis to the national 
institute for infectious disease control by  fax.  Data is tabulated by  year by county by 




Data will be reported by computer diskette by post to co-ordinating centres at Oslo and 
in  Uppsala  University.  Participating  countries  will  be  Denmark,  Finland,  Norway, 
Iceland. 
International feedback 
None as yet.  Format to be decided. 
Date of i) commencement 
i)  1991  (Planning) 
Increasing  the  understanding  of the  contributory  factors  to  disease  development  and 
spread. 
42 B- Training 
European Field Epidemiology Training Program 
Participants 
Medical, Veterinary and Public Health Graduates from European countries.  Initially 6-12 
in number. 
Duration and Locations 
1 month theoretical training at a rotating location followed by 22 months field attachment 
in a country. other than that from which the student comes. 
Subject matter 
Applied epidemiology of Communicable Diseases and Environmental Hazards. 
A working knowledge of  English and the language of  the country where field attachment 
is to be performed is required in practice although languages will not be used as a criteria 
for admission to the course. 
Assessment (including formal  qualifications awarded) 
None although certain educational objectives will be set such as the ability to: 
1) Influence decision makers in  Public Health. 
2) Assume service responsibility in epidemiology and respond to disease clusters. 
3) Develop and maintain an international perspective. 
Benefit to participants 
Comprehensive training in field epidemiology and decision making in acute Public Health 
problems. 
Development of a cadre of professionals with a commitment to addressing Public Health 
problems at the European level. 
Develop a common approach to many problems based on a common training which will 
facilitate harmonisation of approaches to problems and decision making in Europe. 
Date of i) commencement 
I 
i) 1995 probably represents the earliest practicable year in which students can be taken. 
43 Proposal for a 
EUROPEAN PARLIAMENT AND COUNCIL DECISION 
creating a network for the epidemiological surveillance 
and control of communicable diseases 
in the European Community EXPLANATORY MEMORANDUM 
1  In its communication COM(93) 559 of 24 November 1993 on the framework for 
action in the field of public health, the Commission outlined the principles and 
strategies to be followed in implementing Community activities directed towards 
the attainment of the health protection objectives laid down by Articles 3(o) and 
129  of the  Treaty  establishing  the  European  Community.  The  role  of the 
Community is to underpin the efforts of the Member States in the public health 
field, to assist in the formulation arid implementation of objectives and strategies, . 
and  to  contribute  to  the  continuity  of health  protection  provision  across  the 
Community, setting as a target the best results already obtained in a given area 
anywhere in the Community. 
2  In  accordance  with  Article  129  of the  Treaty  establishing  the-- European 
Community, the Commission presents proposals for the adoption by the European 
Parliament and the Council of  incentive measures intended to contribute towards 
ensuring a  high  level  of human health  protection.  These measures  are geared 
towards encouraging cooperation between the Member States, lending support to 
their actions and promoting coordination of their policies and programmes, and 
towards  fostering  cooperation  with  third  countries  and  with  international 
organisations competent in the sphere of public health. This present Commission 
proposal,: 'based  on  Article  129  and  already  announced  in  the  Commission's 
programme of work for  1995,  comes under the principle of shared competence 
between the Community and the Member States and seeks to create a network for 
the  epidemiological  surveillance  and  control  of communicable diseases  in the 
European Community. Full participation by the Member States in the organisation 
and implementation of  the network should help to ensure coordination and. mutual 
cooperation in the collection, processing and exchange of information necessary 
for the prevention and control of  communicable diseases. This Community action 
is therefore geared towards disease prevention and will follow the principles of 
subsidiarity and proportionality. 
3  Infectious diseases  caused by various microbial  agents  tend  to  spread  through 
populations and through space, essentially as a result of  the movements of  people 
and,  to a lesser extent,  the movement of goods and the distribution of drinking 
water and foodstuffs. Additional factors include climatic change (global warming), 
increased resistance to antibiotics,  the immunological  status of individuals,  and 
living conditions (socio-economic problems). The more that people travel about, 
and the further they travel, the greater the risks of  these diseases spreading in the 
form of epidemics and, as a corollary, the greater the health risks to populations. 
From Asian flu  and cholera,  to the InV virus responsible for AIDS,  examples 
abound  both  in  history  arid  in  th~ present  day.  The  agents  responsible  for 
communicable infectious diseases know no  geographical  frontiers.  And  despite 
substantial  progress  in  the  field  of public  health  protection,  the  exposure  of 
populations to the risk of contracting these diseases is increasing all the time. 
ys 4  In order to take the appropriate measures necessary to block the  progression of 
these infectious diseases or prevent their appearance,  national  health authorities 
clearly  need  to  have  as  precise  a  picture  as  possible  of the  epidemiological 
situation.  This can only be achieved through the systematic collection,  analysis 
and interpretation of data on these diseases, followed by dissemination of  the data 
to those responsible for public health.  Taken together these activities amount to 
epidemiological surveillance, an essentially practical process the aim of which is 
to  produce  information  so  that  swift  action  can  be  taken.  In  the  case  of 
communicable  diseases  all  the  specialists  agree  that  the  cornerstone  is 
surveillance,  with  the results being used  in order to control  and  prevent these 
diseases. Epidemiological surveillance has proved its worth over and over again, 
the outlay required being amply repaid by the savings made in terms of disease 
avoidance. 
5  In this general  context, if we look at the European area as  a single_ entity it is 
obviously  essential  to  standardise  communicable  disease  surveillance.  In this 
respect the Council and the Ministers for Health of the Member States meeting 
within the Council adopted on 13 November 1992 a Resolution, No 92/C 326/1 I, 
inviting the Commission to report briefly on the existing arrangements established 
between the Member States or by the World Health Organisation (WHO) for the 
surveillance of communicable diseases, including food-borne diseases; to identify 
needs and shortcomings; and to put forward proposals for improvements. And the 
European Parliament, in its Resolution on public health policy after Maastrichtl, 
invited  the  Commission  to  set  up  a  trans-frontier network  to  devise  working 
definitions  of notifiable  diseases,  to  collect,  update,  analyze  and  disseminate 
Member  State  data  on  notifiable  diseases  and  to  work  with  national  and 
international agencies on these matters. Additionally, in its Conclusions No 94/C 
15/04  of 13  December  1993
3
,  the  Council  requested  the  Commission  to  put 
forward  proposals  for  the  setting  up  of an  epidemiological  network  in  the 
Community.  In its Communication COM(93) 559 of 24 November-1993  on the 
framework  for  action  in  the  field  of public  health  and  its  Communication 
COM(94)  413  of 9 November 1994  on  AIDS  and  certain other communicable 
diseases, the Commission proposed specific Community measures in this respect, 
notably the creation and development of surveillance networks.  To this end, the 
Commission proceeded to consult outside experts, including both national experts 
competent in the surveillance and control  of communicable diseases and senior 
officials of  the national Health Ministries sitting on the High Level Committee on 
Health, and has taken their comments fully into account. 
6  Consequently, this proposal seeks to establish a system of close cooperation and 
effective coordination between Member States in the field  of surveillance, both 
routine and emergency, with a view to improving the prevention and  control of 
a  certain  number  of  serious.  communicable  diseases  which  necessitate  the 
2 
3 
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'16 introduction  of measures  for  the  protection  of populations.  The  proposal  is 
modelled  on  Community  instruments  already  adopted  in  similar  areas  for  the 
accomplishment of similar objectives.  The data in question will be collected in 
aggregated form and will  and will  in no case enable individuals to be identified. 
Thus, they will not conflict with existing or forthcoming Community instruments 
concerning the protection of personal data, such as Council Directive C 95/46/EC 
of 24 O_ctober 1995 on the protection of individuals with regard to the processing 
of personal data and the free movement of such data
4
. They will however comply 
with  the  Community  provisions  concerning  systems  of information  exchange 
between administrations.  In addition,  the Decision contains specific  provisions 
aimed at ensuring cohesion with other relevant Community policies,  namely the 
Common Agricultural Policy, freedom of movement of goods and persons, and 
exchanges of data between administrations. 
7  The setting up of  this network for the surveillance of  communicable di~eases takes 
account of, and is based on, the situation already existing in this field at European 
leveL  It also aims to avoid unnecessary duplication of work by ensuring that all 
Member States have the same conception of surveillance, as a result of defining 
with them the type of information required and the arrangements appropriate for 
each group of communicable diseases.  Finally,  other parties will  be associated 
with the networJs  under arrangements yet to be worked out These will include 
the  competent  international  organisations,  non-member countries  (such  as  the 
United States of America,  with whom  cooperation is already planned),  and the 
surveillance networks to which Member States already belong. 
8 ·  The implementation of the decision will yield added value in a number of ways: 
4 
a)  It will  ensure the  se~ng up of a system of continuous, well-structured, 
reliable  and  effective  communication  at  Community  level  between  national 
communicable  disease  surveillance  authorities,  something  which  is  lacking  at 
present; 
b)  It will facilitate the rapid, reliable and commonly a_greed identification of 
cases of communicable diseases occurring inside the Community,  or occurring 
outside and  therefore being imported or likely to be imported; 
c)  It will  give the competent authorities the opportunity  and  the means to 
consult together on the preventive measures to be taken, and it will help them in 
the  coordinated  introduction  of such  measures  and  the  evaluation  of their 
effectiveness; 
d)  It will  give  the  authorities  the  support  they  need  for  analysing  and 
interpreting data and for deploying the necessary measures to stop communicable 
diseases from spreading. 
OJ No L 281, 23.11.1995, p.31 
'i-t 9  The  action  envisaged  can  only  be  undertaken  on  the  basis  of a  European 
Parliament and  Council decision adopting the measures proposed for the setting 
up of a Community system needed to ensure cooperation between Member States 
and coordination of their respective systems in this area.  It does not require the 
harmonisation of national laws and regulations. Proposal for a 
EUROPEAN PARLIAMENT AND COUNCIL DECISION 
creating a network for the epidemiological surveillance 
and control of communicable diseases 
in the European. Community 
THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN 
UNION, 
Having  regard  to  the  Treaty  establishing  the  European  Community,  and  m 
particular Article 129 thereof, 
Having regard to the proposal from the Commission
1
, 
Having regard to the opinion of the Economic and Social Committee
2
, 
Having r~gard to the opinion of the Committee of the Regions
3
, 
1  Whereas the prevention of  diseases, and in particular of  the major health scourges, 
is a priority for Community action, requiring a global and coordinated approach 
between Member States, 
2  Whereas the European Parliament, in its Resolution on public health policy after 
Maastricht
4
,  invited the Commission to set up a trans-frontier network to devise 
working  definitions  of notifiable  diseases,  to  collect,  update,  analyze  and 
disseminate Member State data on notifiable diseases and to work with national 
and international agencies on these matters, 
3  Whereas in its resolution of2 June 1994 on the framework for Community action 
in the field of public healths the Council agreed that priority should be given at 
present to communicable diseases in particular; 
4  Whereas in  'its conclusions of  13  December 1993
6
, the Council considers that there 
is  a  need  to  develop  at  Community  level  a  network for  the  surveillance  and 
control of communicable diseases, the main purpose of which would be to collect 
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OJ No C 329, 6.12.1993, p. 375 
OJ No C 165, 17.6.1994, p.l. 
OJ No C 15, 18.1.1994, p.  6. 5  Whereas  in  these  same  conclusions  the  Council  requests  the  Commission  to 
devote special attention, in its proposals relating to the framework for action in 
the  field  of public  health
7
,  to  setting  up  an  epidemiological  network  in  the 
Community,  taking account of current proceedings and  mechanisms existing at 
Community level and that of  Member States, and ensuring the comparability and . 
compatibility of data; 
6  Whereas in their resolution of 13  November 1992
8
,  the Council and the Ministers 
for Health meeting within the Council  underline the desirability  of improving, 
within  the  Community,  the  coverage  and  effectiveness  of existing  networks 
between Member States (including data-processing networks), and of  maintaining, 
establishing or strengthening coordination between them for monitoring outbreaks 
of communicable diseases, where such action could add to the value of existing 
measures; 
7  Whereas in this same resolution, the Council and the Ministers for Health meeting 
within the Council underline the value of collecting data from the Member States 
on a limited number of rare and serious diseases which require large samples for 
epidemiological study; 
8  Whereas in this same resolution, the Council and the Ministers for Health meeting 
within the Council invite the Commission to examine the desirability of giving 
priority t.P  certain suitable proposals relating to the control  and surveillance of 








Whereas, in accordance with the principle of subsidiarity, any new measure taken 
in an area which does not fall within the exclusive competence of  the Community, 
such as the epidemiological surveillance and control of communicable diseases, 
may be taken by the Community only if, by reason of the scale or effects of the 
proposed action, the objectives of the proposed action can be better achieved by 
the Community than by one or more Member States; 
Whereas  measures  in  the  health  field  must  take  into  account  other  actions 
undertaken by  the  Community  in  the  field  of public health  or which  have  an 
impact on public health; 
Whereas  European  Parliament  and  Council  Decision  .  ../. ..  IEC  adopting  a 
programme of Community action on the prevention of AIDS  and  certain other 
communicable diseases within the framework for  action  in  the  field  of public 
healtli
9  envisages  a  number  of  Community  actions  for  the · creation  and 
development of networks for the control and surveillance of  certain communicable 
COM(93) 559 final, 24.11.19930 
OJ No  C 326,  11.12.1992, po  1. 
OJ No  000 
So diseases,  the early  detection of such diseases,  and  promotion of the training of 
field epidemiologists; 
12  Whereas cooperation with the competent international organisations, notably with 
regard to disease classification, must be fostered; 
13  Whereas cooperation with third countries, notably in the case of the emergence 
or resurgence of serious communicable diseases, must be supported; 
14  Whereas the emergence or recent resurgence of serious communicable disea:es 
has demonstrated that when an emergency situation occurs all relevant information 
must  be  communicated  swiftly  to  the  Commission  in  an  agreed  form  of 
presentation~ 
15  Whereas the introduction of  specific Community arrangements will help to ensure 
that  al~ Member States are swiftly informed in the event of such an  emergency 
situation, so that the protection of the population can be ensured; 
'16  Whereas the provisions of Council Directive 92/117/EEC
10 concerning measures 
for protection against specified zoonoses and specified zoonotic agents in animals 
and  products  of animal  origin  in  order  to  prevent  outbreaks  of food-borne 
infections  and  intoxications apply  equally  to information concerning zoonoses 
which affect human beings, and whereas the same directive provides for a system 







Whereas the setting up  of a  network for  the  epidemiological  surveillance and 
control  of communicable diseases at Community level  necessarily  presupposes 
observance of the legal  provisions concerning the protection of individuals with 
regard to the processing of personal data and the introduction of  arrangements to 
guarantee the confidentiality and security of such data and information; whereas 
in  this connection the European Parliament and  the .Council  adopted Directive 
95/46/EC on 24 October 1995, 
Whereas the Community projects in the field of the telematic interchange of data 
between administrations (IDA)
11 and the G7 projects should be closely coordinated 
with the implementation of the Community actions relating to the epidemiological 
surveillance and control of communicable diseases; 
Whereas it is important, in an emergency situation,. that the competent national 
structures  should  strengthen  their  cooperation,  notably  with  regard  to  the 
identification of biological samples; 
OJ No L 62,  15.03.93, p.  38. 
OJ No L 269, 11.11.1995, p.23. 20  Whereas these Community arrangements for the rapid exchange of  information do 
not affect the Member States' rights and obligations under Treaties or bilateral and 
multilateral conventions; 
21  Whereas it is important that the Commission should implement the Community 
network  in  close  cooperation  with  the  Member  States;  whereas  a  procedure 
therefore needs to be established to ensure the Member States' full  participation 
in this implementation; 
22  Whereas an agreement on a modus vivendi between the European Parliament, the 
Council and the Commission concerning measures for the implementation of  acts 
adopted under the procedure laid down in Article 189b of  the Treaty was reached 
on 20 December 1994; HAVE DECIDED AS  FOLLOWS: 
Article 1 
A  general  network  for  the  epidemiological  surveillance  and  control  of 
communicable diseases shall be set up in the European Community. 
This  Community  network  shall  be  formed  by  putting  into  permanent 
communication  with  one  another,  through  all  appropriate  technical  means, 
structures which,  at the level of each member State and under the responsibility 
of the  Member  State,  are  charged  with  collecting  information  relating  to 
epidemiological surveillance and coordinating control measures. 
Article 2 
·For the purposes of this decision the  following terms  shall  have the following 
meanings: 
1 - epidemiological surveillance:  the  ongoing  systematic  collection,  analysis, 
interpretation and dissemination of  health data concerning communicable diseases, 
for the purpose of enabling appropriate counter-measures to be taken; 
2  - control of communicable  diseases:  the  range  of measures  taken  by  the 
competent public health authorities to stop the spread of communicable diseases, 
as well as epidemiological studies, in particular of the pattern of spread of such 
diseases over time and space and analysis of  the risk factors for contracting such 
diseases,  the  results  of which  enable  appropriate  preventive  measures  to  be 
devised. 
Article 3 
For  every  Member  State,  the  epidemiological  surveillance  and  control  of 
communicable diseases at Community level shall apply to: 
a)  the appearance or resurgence on its territory of  cases ofserious and/or rare 
communicable diseases as listed in the Annex; 
. b)  the importation onto its territory,  from  another Member State or a non-
Community country, of  cases of  serious and/or rare communicable diseases 
as listed in the Annex. 
S.3 Article 4 
Fot the purposes of implementing this decision the Commission shall be assisted 
by a committee consisting of representatives from the Member States and chaired 
by a representative of the Commission. 
The  Commission  representative  shall  submit  to  the  committee  a  draft  of the 
measures to be taken. The committee shall deliver its opinion on this draft within 
a time limit which the chairman shall lay down according to the urgency of the 
matter. The opinion shall be delivered by the majority laid down in Article 148(2) 
of the Treaty in the case of decisions which the Council is required to adopt on 
a proposal from the Commission. The votes of  the representatives of  the Member 
States  within the  committee  shall  be weighted  in  the  manner  set  out in  that 
Article. The chairman shall not vote. 
The Commission shall  adopt the measures envisaged if they  are in accordance 
with  the  opinion  of the  committee.  If the  measures  envisaged  are  r:tot  in 
accordance with the opinion of  the committee, or if  no opinion has been delivered, 
the Commission shall forthwith submit to the Council a proposal concerning the 
measures to be taken. The Council shall act by a qualified majority. 
If,  within· three months of the matter being referred to  it,  the Council ·has  not 
adopted  !Jleasures,  the  Commission  shall  adopt  the  measures  proposed  and 
implement them immediately. 
Article 5 
The measures referred to in Article 4 concern in particular: 
case definitions, in particular the clinical definition and, where appropriate, 
the microbiological characterisation of the agent responsible; 
the  nature  and  type  of data  and  information  to  be  collected  by  the 
structures  referred  to  in  Article  1  in  the  field  of  epidemiological 
surveillance; 
the epidemiological and microbiological surveillance methods; 
the  protective measures to be taken,  in  particular  at  ports  and  airports, 
notably in emergency situations; 
information, recommendations and guides to good practice for the public; Articie 6 
Each  structure  referred  to in  Article  1 shall  communicate  to  the  Community 
network and the Commission: 
information on the communicable diseases referred to in Article 2, together 
with information on control measures applied; 
any useful information concerning the progression of epidemic situations 
in the Member State to which the institution belongs; 
any evaluation element which will aid cooperation between Member States 
for the purpose of the control of communicable diseases, in particular the 
conservation of biological samples taken from patients for transmission to 
specialist laboratories linked to the Community network. 
Article 7 
Each Member State shall appoint, within six months following the entry into force 
of  this decision, the structure or structures referred to in Article 1, and shall notify 
the Commission thereof. 
Artide 8 
The Commission may amend or supplement the Annex in accordance with the 
procedure provided for in Article ~-
Article 9 
This  decision  shall  apply  without  prejudice  to  Council  Directive  92/117/EC 
concerning  measures  for  protection  against  specified  zoonoses  and  specified 
zoonotic agents  in  animals  and  products  of animal  origin  in  order to prevent 
outbreaks of  food-borne infections and intoxications, and shall take account of  the 
information collection and transmission procedure provided for in that directive. 
Article 10 
This decision shall  apply without prejudice to European Parliament and Council 
Directive 95/46/EC on the protection of individuals with regard to the processing 
of personal  data  and  on  the  free  ·movement  of such  data,  and  to  Council 
Decision 95/468/EC on a Community contribution for telematic interchange of 
data between administrations in the Community (IDA). Article 11 
This decision  shall  not affect Member States'  reciprocal  rights and  obligations 
deriving  from  existing  or  future  bilateral  or  multilateral  agreements  or 
conventions in the domain covered by the decision, and which are in line with the · 
decisi~n's subject, methods of implementation and objectives. 
Article 12 
This decision ~s addressed to the Member States and shall enter into force three 
months after the date of its publication in the Official Journal  of the European 
Communities.  · 
Done at Brussels 
For the European Parliament 
The President 
S( 
For the Council 
The President ANNEX 
The communicable diseases  referred to in Article 3 are divided  into groups of 
serious and/or rare disorders, namely: 
-concerning paragraph a): 
diseases  requiring measures  to  be taken at  local  level  and  reported  on 
periodically to the Member States'  public health authorities in accordance with 
arrangements specific to each of these diseases and  defined in  accordance with 
Article 5,  notably:  ·. 
- diseases  preventable  by  vaccination  (tuberculosis,  tetanus,  poliomyelitis, 
diphtheria,  meningitis,  measles,  mumps,  rubella,  influenza  and  influenza 
syndromes, etc.), 
- sexually-transmitted diseases (hepatitis B, AIDS/IllY, chlamydiasis, etc.), 
- viral hepatitis (including hepatitis C and other as yet unclassified categories of 
hepatitis), 
- food-borne diseases (listeriosis, salmonellosis, etc.), 
- water-borne diseases and diseases of environmental origin (legionellosis, etc.), 
- nosocomial  infections, 
- other diseases transmissible by non-conventional agents (including Creutzfeldt-
Jakob disease, etc.). 
- concerning paragraph b): 
the  same  diseases  as  under  paragraph  a),  plus  diseases  requmng 
exceptional measures to be taken at national and international levels, such as: 
-diseases covered by the International Health Regulations (yellow fever, cholera, 
plague) 
- other diseases (rabies, typhus fever,  African haemorrhagic fevers,  malaria and 
any other as yet unclassified serious epidemic disease, etc.). 
S-=t FINANCIAL STATEMENT 
1  TITLE OF OPERATION 
Proposal for a European Parliament and Council decision creating a network for 
the  epidemiological  surveillance and  control  of communicable  diseases  in the 
European Community. 
2  BUDGET HEADING INVOLVED 
Part A of the Qudget. 
3  LEGAL. BASIS 
a) Actual legal basis: 
Article 3(o) and Article 129 of the Treaty on European Union. 
b) References: 
Conclusions of the Council and the Ministers for Health of the Member States 
meeting within the Council of 16 May 1989 on the improvement of the general 
system for collecting epidemiological data, including the application of the new 
definition of AIDS cases (OJ No C 185, 22.7.1989, p.  7). 
Resolution of the Council  and the Ministers for Health of the Member States 
meeting  within  the  Council  of  13 November  1992  on  the  monitoring  and 
surveillance of communicable diseases (OJ No C 326, 11.12.1992, p.  1). 
Commission communication on the framework for action in the field of public 
health (COM (93) 559 final,  24 November 1993). 
Council conclusions of 13  December 1993 on the setting up of an epidemiological 
network in the European Community (OJ No C 15,  18.1.1994, p.  6). 
sg 4  DESCRIPTION OF OPERATION 
4.1  General objective 
Implementation  at  Community  level  of a  system  of epidemiological 
surveillance in the field of communicable diseases, to meet the following 
objectives: 
firstly,  to  ascertain  the  incidence  and  the  characteristics  of a 
particular infectious disease or group of diseases, and to study the pattern 
of swead of the disease through time, space and social  categories, so as 
to be able to take appropriate counter-measures; 
secondly, to detect disease clusters or epidemics, or even abnormal 
health  incidents,  so. that  measures  can  be taken  to break  the  specific 
transmission chain; 
thirdly, to describe and measure the risk factors for contracting a 
communicable infection, so as to be able to select and implement the most 
appropriate preventive measures and recommendations. 
4.2  Method employed for attaining these objectives 
The setting up and running of  a system for the surveillance and control· of 
communicable diseases at Community level,  requiring the exchange,  at 
appropriate  moments,  of accurate  and  reliable  information  concerning 
diseases  for  which  specific  case  definitions,  identifications  and 
verifications are required. It is proposed to setup this system on the basis 
of a  European  Parliament  and  Council  decision,  and  to  exploit  the 
infrastructure set up by the IDA programme. 
4.3  Period covered 
Open-ended. 
Implementation  report  to  be  transmitted  to the  Council  and the 
European Parliament following the creation of the network,  and 
further reports to be transmitted following any adaptations to the 
system. 
5  CLASSIFICATION OF EXPENDITURE OR RE\'¥NUE 
Non-differentiated appropriations. 6  TYPE OF EXPENDITURE OR REVENUE 
Nil 
7  FINANCIAL IMPACT 
No financial impact in Part B of the budget. 
8  ANTI-FRAUD MEASURES PLANNED 
\, 
Measures in the rules on the reimbursement of travelling and subsistence costs of 
experts convened. 
9  ELEMENTS OF COST-EFFECTIVENESS ANALYSIS 
9.1  Specific and quantifiable objectives: 
The aim is to  establish  a  Community  network for  the  epidemiological 
surveillance  and  control  of commuhicable  diseases,  by  achieving  the 
following objectives: 
setting  up  of  a  system  of  close  cooperation  and  effective · 
coordination between Member States in the field of surveillance,  both 
routine  and  emergency,  with  a  view to  improving  the  prevention  and 
con_!:rol  in Europe of a certain number of serious communicable diseases 
which  necessitate  the  introduction  of mea.Sures  for  the  protection .. of 
populations; 
list of diseases and/or groups of diseases kept under surveillance 
at Community level; 
case  definitions,  in  particular the  clinical  definition  and,  where 
appropriate, the microbiological characterisation of the agent responsible; 
the nature and type of data and information to be collected in the 
context of epidemiological surveillance; 
epidemiological and microbiological surveillance methods; 
protective measures to be taken, in particular at ports and airports, 
notably in emergency situations; 
information, recommendations and guides to good practice for the 
public; 
designation  of  the  structure  responsible  for  coordination  for 
particular diseases and/or groups of diseases. 
6a 9.2  Players concerned 
1.  The  Member  States'  competent  health  authorities  at  national, 
regional and local levels, and competent international organisations. 
2.  Health professionals, institutions, laboratories and epidemiological 
health services. 
9.3  Grounds for the operation 
As regards the setting up of a system for the surveillance and  control of 
communicable  diseases  at  Community  level,  the  Commission,  in  its 
communication of 24· November 1993 on the framework for action in the 
field of public health, outlined the principles and strategies to be followed 
in implementing Community activities directed towards the attainment of 
the health protectionobjectives laid down by Articles 3(o) and 129 of the 
Treaty establishing the European Community. The role of  the Community 
is to underpin the efforts of the Member States in the public health field, 
to  assist  in  the  formulation  and  implementation  of ·objectives  and 
strategies, and to contribute to the continuity of  health pr:otection provision 
across the Community, setting as a target the best results already obtained 
in a given area anywhere in the Community. 
The Commission's. proposal for the creation of such a network advocates 
that the Member States  should  participate fully  in  its organisation  and 
implementation. The network's task will be to ensure coordination in the 
collection,  processing  and  exchange  of information  necessary  for  the 
prevention  and  control  of communicable diseases.  Focusing on disease 
prevention, and following the principles of  subsidiarity and proportionality, 
this Community operation is designed to enable the authorities responsible 
for  public  health  to  take,  at  national  level,  measures  to  block  the 
progression of these infectious diseases or to prevent their appearance. 
An  operation as extensive as the creation and development of a network 
which will  link the competent authorities of all  Member States can only 
be undertaken on a Community scale. 
9.4  Monitoring and evaluation of the operation 
9. 4.1  Monitoring of  the operation 
The setting up  and  functioning of the network will  be monitored 
by the Commission, which will submit reports to the Council, the 
European Parliament, the Economic and Social Committee and the 
Committee of the Regions.  The Commission will  base its reports 
·on the national  reports and on any  evaluations carried out. 9. 4. 2  Evaluation 
* Evaluation will take the form of: 
an evaluation of  the effective establishment of  the network, 
with the participation of independent experts; 
reports  on the quality. and  effectiveness  of the network's 
functioning,  to  be  submitted  by  the  Commis~ion to  the  other 
Community institutions. 
* Evaluation methods and intervals: 
establishment of regular reports on any adaptations which 
may be introduced. 
10  ADMINISTRATIVE  EXPENDITURE (PART A OF THE BUDGET) 
The effective mobilisation of  the administrative resources required will result from 
the Commission's annual decision on the allocation of resources, taking account 
of any additional staff and funds allocated by the budgetary authority. 
10.1  Effect. on the number of workers 
Types of  workers  Staff iunning the operation  Source of the workers  Duration 
-
Permanent  Temporary  DGor  Additional 
workers  workers  set'Vlce  personnel 
Officials, or  A  1  0  1  ·o 
temporary  B  1  1  0 
staff  c  1  1  0 
Other resources 
-
Total  3  0  3  0 
10.2  Financial impact of employing additional staff 
Nil 10.3  Increase  in  other  administrative  expenditure  resulting  from  the 
operation 
Budget heading  Amount  Method of work 
Meetings A251 0  92 650  * 4 meetings of the committee, 2 
representatives/Member State, 
4 x 30 x 770 Ecus 
~ ~ 
The resources needed to cover the expenditure described pel ow will be 
obtained  by  redeploying  existing  financial  resources;  no  additional 
resources will be required. 
Staff expenditure (Titles A1,  A2 and AS) 




Cost of meetings (A-250) 
3 meetings x 15 _expertsx 879 Ecus =  39.555 Ecus 
Mission costs (A-130) 
24 Brussels-Luxembourg missions x 200 Ecus =  4 800 Ecus 
30 Member States missions x 750 Ecus =  22 500 Ecu,s 
366 855 Ecus ISSN 0254-1475 
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